简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-11-12 19:58 25 Years of Making the World a Better Place for Women: Mary Kay Ash FoundationSM Marks Milestone Anniversary
2021-11-12 19:55 Celltrion Receives CHMP Positive Opinion for regdanvimab (CT-P59) as One of the First Monoclonal Antibodies Recommended as a Treatment for COVID-19 by the CHMP
2021-11-12 15:11 GrowthOps Joins the Alida Partner Network to Elevate Customer Experiences in Asia-Pacific
2021-11-12 15:04 VFMCRP receives positive CHMP opinion for Tavneos® for the treatment of ANCA-associated vasculitis
2021-11-11 20:50 Exscientia to Report Third Quarter 2021 Financial Results on November 17, 2021
2021-11-11 16:28 Alentis Therapeutics Announces Appointments of Luca Santarelli to the Board of Directors and Rafaèle Tordjman as Chairperson
2021-11-11 14:30 Rory McIlroy, Daniel Ricciardo, Connor McDavid, Klay Thompson, Jayson Tatum and More Join Naomi Osaka, Erling Haaland and Virat Kohli as Hyperice Athlete-Investors to Fuel Global Growth
2021-11-09 17:46 Masimo Root® with a Multimodal Brain Monitoring Algorithm May Improve Postoperative Neurocognition in Elderly Patients
2021-11-09 16:45 Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology
2021-11-09 16:13 IntelliCentrics and EUCARE Announce Strategic Partnership Supporting Delivery of Taiwan’s High-Quality, Integrated Medical Services to the World
2021-11-09 09:11 Philip Morris International Announces Stamford Central Business District as Location of New Corporate Headquarters
2021-11-08 10:02 ENYO Pharma Announces Two Vonafexor Data Presentations at AASLD The Liver Meeting
2021-11-08 09:21 Empagliflozin shows consistent cardio-renal benefits in adults with heart failure with left ventricular ejection fraction over 40 percent regardless of chronic kidney disease status
2021-11-05 22:26 The Estée Lauder Companies Releases Fiscal 2021 Social Impact and Sustainability Report
2021-11-05 15:22 Consensus Cloud Solutions to Host Investor Call on November 9, 2021
2021-11-04 20:52 Registration Opens for SPIE Photonics West 2022
2021-11-04 18:45 Rhizen Pharmaceuticals AG Announces First Patient Dosing in a Phase I/Ib Study of Its Novel PARP Inhibitor (RP12146) in Patients With Advanced Solid Tumors
2021-11-04 18:41 Rapid Medical to Initiate the First-Ever Trial to Expand Stroke Treatment to Distal Regions of the Brain–Offering Thrombectomy Treatment to New Patient Population
2021-11-04 14:25 PierianDx Closes up to $47.5 Million of Growth Capital
2021-11-03 18:52 Sumitomo Heavy Industries Succeeds in Developing a Superconducting Cyclotron for Proton Therapy

Business Wire Weibo

Press Releases

Latest Releases